집
현대 직장에서의 유교 윤리 분석
철학/종교
35
35
유교 핵심 윤리 관점을 정리하고 현대 기업 직장 시나리오에서 현대 적응성과 실천 가치를 분석하며 전통 관념과 현대 규범의 균형을 맞추는 참고 방향을 제시한다.
프롬프트 내용
복사
복사
Sort out core Confucian ethical concepts including benevolence, righteousness, propriety, wisdom, trustworthiness and the emphasis on hierarchical order, combine specific scenarios such as cross-department collaboration, superior-subordinate communication and professional integrity in contemporary Chinese corporate workplaces, analyze the compatible parts and points that need adjustment of traditional Confucian ethics in current workplaces, sort out practical directions suitable for modern workplaces, balance the relationship between traditional ideology and modern enterprise management norms, and output clear and referable sorting results.
복사
인(仁), 의(義), 예(禮), 지(智), 신(信)과 위계 질서 중시 등 유교의 핵심 윤리 관점을 정리하고, 현대 중국 기업 직장의 부서 간 협업, 상하급 소통, 직업 윤리 등 구체적인 장면과 결합하여 전통 유교 윤리가 현재 직장에서 적합한 부분과 조정이 필요한 부분을 분석하며, 현대 직장에 적합한 실천 가능한 방향을 정리하고 전통 사상 문화와 현대 기업 경영 규범 간의 관계 균형을 맞춰 명확하고 참고할 수 있는 정리 결과를 출력한다.
복사
의견 (0)
0/300
추천
윤리적 의사결정 지원
Act as a corporate ethics committee to conduct a deep ethical assessment of the following specific business scenario: A major pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Combine the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent to analyze the moral weight of three strategies: concealing information, issuing public warnings, or initiating a recall. Avoid simple right-or-wrong judgments; instead, construct a multi-dimensional evaluation framework including stakeholder impact, legal risks, brand reputation, and social trust. Finally, output an advisory action guide that aims to balance business sustainability with patient welfare, ensuring the decision-making process is transparent and adheres to the highest ethical standards.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, yet a recall would bankrupt the company and lay off thousands. Evaluate the ethical weights of recalling versus not recalling by combining utilitarian calculations for the greatest good with deontological respect for human dignity, and provide a specific action plan that balances social responsibility with corporate survival, focusing on how to build public trust through transparent communication.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the moral dilemma in the following business scenario: A pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Please weigh the benefits of disclosure against the risks of concealment, combining utilitarian consequence assessment with deontological respect for informed consent. Finally, provide a specific action plan that balances patient safety, corporate reputation, and legal compliance, focusing on how to maintain trust through transparent communication while minimizing potential harm.
윤리적 의사결정 지원
Act as a corporate ethics consultant to conduct a deep moral deduction on the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but irreversible neurological side effects with long-term use, yet stopping medication carries higher risks and alternative therapies are less effective. Please analyze the ethical weight of four strategies—disclosing information, adjusting pricing, reformulating, or withdrawing from the market—by balancing utilitarian calculations for the greatest good against deontological adherence to patient知情权 and non-maleficence. Provide a final action recommendation that balances business sustainability with social responsibility, focusing on how to build trust through transparency and patient safety.
윤리적 의사결정 지원
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-listed common drug may cause severe side effects in a very small group of patients with specific genetic profiles, but the recall cost is extremely high and could lead to drug shortages affecting the majority of patients. Please evaluate the moral rationality of three options—full recall, partial recall, or continued sales—by combining the utilitarian principle of maximizing happiness with the deontological obligation to respect individual rights and the duty of honest disclosure. Provide the best course of action that balances the interests of all parties and aligns with corporate social responsibility, focusing on the ethical trade-off logic in the decision-making process.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but predictable side effects with long-term use, yet stopping production would leave millions of dependent patients without basic treatment. Please evaluate whether the drug should be voluntarily recalled by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological duty to honestly inform patients of risks. In your analysis, weigh shareholder interests, patient safety, legal compliance, and social trust, and provide a specific action recommendation that balances ethical responsibility with business sustainability, avoiding abstract theoretical stacking and focusing on the practical execution level of ethical trade-offs.
